• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 3. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 4. Distribution characteristics of nitrogen and the related microbial community in the surface sediments of the Songhua River?
  Congyu Li,Wenfu Wang,Haiyan Wang,Guokai Yan,Weiyang Dong,Zhaosheng Chu,Huan Wang,Yang Chang RSC Adv., 2021,11, 26721-26731
• 5. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Biotin and derivatives Biotin and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Biotin and derivatives

Introduction to 5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanoic Acid (CAS No. 57378-70-8)

5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanoic acid is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and bioorganic synthesis. This compound, identified by its CAS number 57378-70-8, is a derivative of the thieno[3,4-d]imidazole scaffold, which is known for its versatile biological activities and potential therapeutic applications. The unique structural features of this molecule, including its pentanoic acid side chain and the oxo group at the 2-position, contribute to its distinct chemical properties and reactivity.

The significance of 5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanoic acid in modern medicinal chemistry lies in its potential as a building block for the development of novel pharmacological agents. The thieno[3,4-d]imidazole core is a privileged structure that has been extensively studied for its role in modulating various biological pathways. Recent advancements in drug discovery have highlighted the importance of heterocyclic compounds in addressing complex diseases, making this compound a promising candidate for further investigation.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting enzymes involved in metabolic and inflammatory pathways. The structural motif of 5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanoic acid suggests that it may interact with key enzymes such as kinases and proteases, which are often implicated in diseases like cancer and autoimmune disorders. The presence of the oxo group and the pentanoic acid side chain enhances its binding affinity and specificity, making it an attractive scaffold for rational drug design.

One of the most compelling aspects of this compound is its potential to serve as a precursor for synthesizing more complex derivatives with enhanced pharmacological properties. The thieno[3,4-d]imidazole ring provides a rigid framework that can be modified to optimize solubility, bioavailability, and target specificity. Additionally, the pentanoic acid moiety offers a site for further functionalization, allowing chemists to tailor the molecule to specific biological targets.

The synthesis of 5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanoic acid involves multi-step organic transformations that require precise control over reaction conditions. Advanced synthetic techniques such as transition-metal-catalyzed cross-coupling reactions and asymmetric hydrogenation have been employed to construct the desired scaffold with high enantiomeric purity. These methods ensure that the final product meets the stringent requirements for pharmaceutical applications.

In vitro studies have demonstrated that derivatives of thieno[3,4-d]imidazole exhibit promising biological activities. For instance, certain analogs have shown inhibitory effects on cyclin-dependent kinases (CDKs), which are critical regulators of cell cycle progression. The mechanism of action of these compounds often involves disruption of protein-protein interactions or modulation of enzyme activity. Such findings underscore the therapeutic potential of 5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanoic acid as a lead compound for drug development.

The growing interest in structure-based drug design has further propelled research into this compound. High-throughput screening (HTS) and computational modeling techniques have been utilized to identify novel derivatives with improved pharmacokinetic profiles. These approaches leverage the known binding interactions between the thieno[3,4-d]imidazole core and biological targets to guide rational modifications.

The versatility of 5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanoic acid extends beyond its role as a pharmacophore. It also serves as a valuable tool in synthetic chemistry for exploring new reaction pathways and methodologies. The development of innovative synthetic strategies not only advances our understanding of organic transformations but also contributes to the broader goal of creating more efficient and sustainable chemical processes.

The future prospects for this compound are promising, with ongoing research aimed at expanding its applications in medicinal chemistry and materials science. Collaborative efforts between academic institutions and pharmaceutical companies are expected to yield novel derivatives with enhanced therapeutic efficacy and reduced side effects. Additionally, advancements in green chemistry principles may facilitate more environmentally friendly synthetic routes for producing this compound.

In conclusion, 5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanoic acid (CAS No. 57378-70-8) represents a significant advancement in the field of pharmaceutical chemistry. Its unique structural features and potential biological activities make it a valuable asset for drug discovery efforts. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in developing next-generation therapeutics.

• 58-85-5(D-Biotin)
• 22879-79-4(VITAMIN H)
• 415725-35-8(9-Methyl Biotin (mixture of diastereomers))
• 1217850-77-5(rac Biotin-d4)
• 608-16-2((+)-Biotin Methyl Ester)
• 1405-69-2(Avidin)
• 60562-11-0(1H-Thieno[3,4-d]imidazole-4-pentanoicacid, hexahydro-2-oxo-, methyl ester, (3aR,4R,6aS)-rel-)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)